Prescription Access Litigation

1. Patients should be able to get the medications they need at a price they can afford.
2. Doctors and patients should decide what drugs to take based on scientific evidence, not drug company marketing.
3. Drug companies should be held accountable for their illegal pricing and marketing tactics.

Public Advocacy

Prescription Access Litigation (PAL) works to make prescription drug prices more affordable for consumers, using class action litigation and public education. PAL and its members seek to challenge illegal pricing tactics and deceptive marketing by drug companies, Pharmacy Benefit Managers, and other pharmaceutical industry players.

PAL is a national coalition of more than 130 organizations, including consumers, seniors, heath care, labor, legal services, women's health and human services groups in 36 states and the District of Columbia.

PAL and its members have been involved in more than 30 class action lawsuits challenging drug industry tactics to illegally raise the price of prescription drugs. To date, there have been 12 settlements in these cases, allowing consumers who were illegally overcharged to be reimbursed and putting drug companies on notice that their illegal tactics will not go unopposed.

PAL is a project of Community Catalyst, Inc., a national nonprofit advocacy organization located in Boston, Massachusetts that builds consumer and community participation in the shaping of the U.S. health system to ensure quality, affordable health care for all.